We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Pulls Wellbutrin Generic After FDA Study Finds Efficacy Issues
Teva Pulls Wellbutrin Generic After FDA Study Finds Efficacy Issues
October 9, 2012
Teva and Impax have ceased shipping their 300-mg generic of GlaxoSmithKline’s antidepressant Wellbutrin XL following an FDA determination that the drug is not therapeutically equivalent to its branded counterpart.